12 Health Care Stocks Moving In Thursday's After-Market Session

Gainers

  • FibroGen FGEN stock moved upwards by 4.99% to $10.73 during Thursday's after-market session. The company's market cap stands at $993.8 million.
  • Advaxis ADXS stock moved upwards by 3.54% to $0.54. Today's trading volume for this security ended up closing at 207.7K shares, which is 2.5 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $78.6 million.
  • Kala Pharmaceuticals KALA shares increased by 3.43% to $2.71. The market value of their outstanding shares is at $176.0 million.
  • Xenetic Biosciences XBIO shares moved upwards by 3.41% to $2.12. The market value of their outstanding shares is at $20.5 million.
  • Cue Health HLTH stock rose 3.13% to $12.18. The company's market cap stands at $1.7 billion.
  • Mereo BioPharma Group MREO shares rose 2.89% to $2.49. The company's market cap stands at $271.1 million.

Losers

  • Alector ALEC stock declined by 5.7% to $21.52 during Thursday's after-market session. Trading volume for this security closed at 64.3K, accounting for 4.11% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $1.7 billion.
  • Regencell Bioscience RGC shares fell 2.43% to $22.1. The market value of their outstanding shares is at $279.4 million.
  • NanoVibronix NAOV stock fell 2.43% to $2.01. The company's market cap stands at $48.4 million.
  • Evofem Biosciences EVFM stock declined by 2.39% to $0.72. The market value of their outstanding shares is at $111.9 million.
  • Aethlon Medical AEMD stock decreased by 2.34% to $3.77. The company's market cap stands at $58.0 million.
  • ASLAN Pharmaceuticals ASLN shares decreased by 2.25% to $1.74. The company's market cap stands at $121.1 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!